Key facts
- This page summarizes Kenneth Reay Code's Form 4 filing for BIOLARGO, INC. (BLGO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2021, 20:54.
Kenneth Reay Code - 05 Oct 2021 Form 4 Insider Report for BIOLARGO, INC. (BLGO)
- Reporting relationship
- Chief Science Officer, Director, 10%+ Owner
- Issuer ticker
- BLGO
- Reported as of
- 05 Oct 2021
- Net transaction value
- +$11,750
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2021, 20:54:54 UTC
- Next SEC filing
- 04 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John R. Browning, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kenneth Reay Code filed Form 4 for BIOLARGO, INC. (BLGO) on 06 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$11,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLGO
transaction
Common stock
Award
- Transaction value
- $11,750
- Shares
- +61,842
- Change %
- +0.25%
- Price
- $0.1900
- Shares after
- 24,581,095
- Date
- 05 Oct 2021
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
Footnote F2
Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.
Footnote F3
The shares issued are unvested and subject to a Lock-Up Agreement dated as of the issuance date whereby shares vest only upon the earlier of (i) the sale of the Issuer of substantially all of its assets, (ii) the successful commercialization of Issuer's products or technologies as demonstrated by its receipt of at least $3,000,000 in cash, or the recognition of $3,000,000 in revenue, over a 12-month period from the sale of products and/or the license of technology; and (iii) the Company's breach of the employment agreement between the Company and Reporting Person and resulting in Reporting Person's termination.